SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001213900-17-004364
Filing Date
2017-04-28
Accepted
2017-04-28 16:10:29
Documents
6
Period of Report
2017-06-08
Effectiveness Date
2017-04-28

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT def14a0417_soligenix.htm DEF 14A 755219
2 GRAPHIC image001.jpg GRAPHIC 1641
3 GRAPHIC image002.jpg GRAPHIC 1619
4 GRAPHIC image003.jpg GRAPHIC 76186
5 GRAPHIC image004.jpg GRAPHIC 165486
6 GRAPHIC image005.jpg GRAPHIC 171616
  Complete submission text file 0001213900-17-004364.txt   1330682
Mailing Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540
Business Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540 609-538-8200
SOLIGENIX, INC. (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-14778 | Film No.: 17795559
SIC: 2834 Pharmaceutical Preparations